Fate Therapeutics Inc. Common Stock (FATE)
Stock · NASDAQ · Health Care
$2.43as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$1.3
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
How Fate Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Fate Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- FATEFate Therapeutics Inc. Common Stock$2.42▼ 4.92%Market cap $291.40MP/E —
- SABSSAB Biotherapeutics Inc. Common Stock$3.79▼ 3.56%Market cap $289.80MP/E 26.94$1.85$5.15
- NMRANeumora Therapeutics Inc. Common Stock$1.38▼ 6.76%Market cap $303.87MP/E —$0.83015$3.65
- LCTXLineage Cell Therapeutics Inc. Common Stock$1.11▼ 4.31%Market cap $276.72MP/E —$1$2.09
- AVXLAnavex Life Sciences Corp. Common Stock$2.98▼ 4.79%Market cap $273.38MP/E —$2.26$10.4
- EDITEditas Medicine Inc. Common Stock$3.15▼ 4.55%Market cap $259.45MP/E —$1.66$4.54
- SRZNSurrozen Inc. Common Stock$22.42▼ 6.62%Market cap $252.87MP/E —$10.73$35
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| FATE Fate Therapeutics Inc. Common Stock | $291.40M | — | $2.42 | ▼ 4.92% | |
| SABS SAB Biotherapeutics Inc. Common Stock | $289.80M | 26.94 | $3.79 | ▼ 3.56% | $1.85$5.15 |
| NMRA Neumora Therapeutics Inc. Common Stock | $303.87M | — | $1.38 | ▼ 6.76% | $0.83015$3.65 |
| LCTX Lineage Cell Therapeutics Inc. Common Stock | $276.72M | — | $1.11 | ▼ 4.31% | $1$2.09 |
| AVXL Anavex Life Sciences Corp. Common Stock | $273.38M | — | $2.98 | ▼ 4.79% | $2.26$10.4 |
| EDIT Editas Medicine Inc. Common Stock | $259.45M | — | $3.15 | ▼ 4.55% | $1.66$4.54 |
| SRZN Surrozen Inc. Common Stock | $252.87M | — | $22.42 | ▼ 6.62% | $10.73$35 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 69.35M
- Total value held
- $77.53M
- Institutional holders
- 151
Top holders this quarter
- Unknown12.87M
- Unknown10.07M
- Unknown4.19M
- Unknown4.12M
- Unknown3.47M
- Unknown3.38M
- Unknown3.00M
- Unknown2.97M
- Unknown2.59M
- Unknown2.26M
See the full, filterable feed with live charts on the MarketWall dashboard.